Dasatinib in solid tumors

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.3, 2010-03, pp. : 415-425

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies

By Argiris Athanassios

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1575-1584

Springer Publishing Company

Access to resources Recommend Favorite

Drug Delivery and Transport to Solid Tumors

By Jang Seong Hoon Wientjes M. Guillaume Lu Dan Au Jessie L.-S.

Pharmaceutical Research, Vol. 20, Iss. 9, 2003-09 ,pp. : 1337-1350

Springer Publishing Company

Access to resources Recommend Favorite

Monoclonal Antibodies in the Management of Solid Tumors

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 16, 2006-08 ,pp. : 1687-1705

Bentham Science Publishers

Access to resources Recommend Favorite

Differentiation-Inducing Therapy for Solid Tumors

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 379-385

Bentham Science Publishers

Access to resources Recommend Favorite

Gastrointestinal Stromal Tumors: A Paradigm for Therapeutic Options in Solid Organ Tumors

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 7, 2010-06 ,pp. : 624-634

Bentham Science Publishers

Access to resources Recommend Favorite